Results
1 -
8 of
8Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells, BMC Proceedings Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines, Journal of Inflammation Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights, Journal of Hematology & Oncology Targeting Survivin in Cancer Therapy: Clinical Considerations, Apoptosome Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias, Investigational New Drugs Survivin in Solid Tumors: Rationale for Development of Inhibitors, Current Oncology Reports Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-??B-dependent transcription of TNF-?? and MCP-1/CCL2 genes by preventing RelA from binding its cognate sites on DNA, Journal of Inflammation Small molecules that prevent teratoma formation in human pluripotent stem cellu2013derived therapies, Science-Business eXchange